BridgeBio Pharma (BBIO) Market Cap 2019–2026

As of November 13, 2026, BridgeBio Pharma had a market cap of $15.35 billion, which increased by 0.20% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Nov 13, 2026, 4:00 PM ET
BridgeBio Pharma logo

BridgeBio Pharma, Inc. (BBIO)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$15.35B ▲ 0.20%
Start of 2026
$14.74B ▲ 4.14%
1 Year Ago
$12.54B ▲ 22.41%
All-Time High
$17.65B ▼ 13.03%


Loading data...

Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 BridgeBio Pharma Market Cap History by Year and Month

BridgeBio Pharma Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$15.35B▲ 4.14%
$15.35B▲ 4.49%
$14.69B▲ 14.32%
$12.85B▼ 14.10%
$14.96B▼ 4.53%
$15.67B▲ 7.48%
$14.58B▲ 12.33%
$12.98B▼ 5.87%
$13.79B▼ 4.24%
$14.4B▲ 11.71%
$12.89B▼ 13.43%
$14.89B▲ 1.02%
2025$14.74B▲ 182.66%
2024$5.215B▼ 25.75%
2023$7.023B▲ 516.59%
2022$1.139B▼ 53.65%
All market cap values reflect closing prices for the period shown.

📊 BridgeBio Pharma Market Cap and Other Industry Peers

Below are selected companies for comparison based on industry, sub-industry, and sector:

  1. $25.06B
  2. $24.68B
  3. $22.09B
  4. $16.96B
  5. $16.88B
  6. $15.35B
  7. $11.42B
  8. $11.32B
  9. $11.08B
  10. $10.88B
  11. $9.93B
  12. $9.46B
  13. $9.17B
  14. $9.04B
  15. $8.54B
  16. $7.97B
  17. $7.81B
  18. $6.74B
  19. $6.61B
  20. $5.3B

Data reflect the most recent market capitalization values available.

Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.